Loading...
XNAS
MHUA
Market cap3mUSD
Dec 04, Last price  
12.55USD
1D
8.00%
1Q
3,291.89%
IPO
39.44%
Name

Meihua International Medical Technologies Co Ltd

Chart & Performance

D1W1MN
XNAS:MHUA chart
P/E
0.37
P/S
0.04
EPS
34.24
Div Yield, %
Shrs. gr., 5y
2.54%
Rev. gr., 5y
4.01%
Revenues
97m
-0.19%
75,706,67979,626,07189,061,010104,037,710103,346,34197,098,91596,909,642
Net income
11m
-6.73%
15,477,65115,431,19719,045,25520,949,5796,242,96911,625,41710,843,589
CFO
15m
+543.16%
11,816,4549,308,3165,325,996-54,663-9,163,0382,275,75014,636,805

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
IPO date
Feb 16, 2022
Employees
626
Domiciled in
CN
Incorporated in
KY

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT